Burton Takes Lead At AAM’s Biosimilars Council
Policy Head Also Adds Strategic Alliances To Role As Simmon Moves To Lead FDLI
Craig Burton is stepping up to become executive director of the US Association for Accessible Medicines’ Biosimilars Council, as Christine Simmon has moved on to become president and CEO of the Food and Drug Law Institute. At the same time, Burton has added oversight of strategic alliances to his existing policy role with the AAM.
